Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 4 Open-market buy Director bought 1,000 shares at $14.38 ($14,381)
  2. 4 Exercise or conversion Director acquired 3,702 shares (option exercise)
  3. 4 Exercise or conversion President and CEO acquired 7,000 shares (option exercise)
  4. 4 Exercise or conversion President and CEO acquired 34,167 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 1,000 shares at $12.46 ($12,460)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 5 Insider Annual Insider Trading Report
  15. 5 Insider Annual Insider Trading Report
  16. 5 Insider Annual Insider Trading Report
  17. 5 Insider Annual Insider Trading Report
  18. 5 Insider Annual Insider Trading Report
  19. 4 Exercise or conversion EVP, CMO acquired 11,210 shares (option exercise)
  20. 4 Open-market buy Director bought 3,000 shares at $10.09 ($30,275)

Page 16 of 24 · 465 filings